Skip to main content
PMC home page
Journal of Clinical and Experimental Hepatology logoLink to Journal of Clinical and Experimental Hepatology
. 2011 Nov 9;1(2):109–114. doi: 10.1016/S0973-6883(11)60129-1

Hepatocyte Transplantation

Ragai R Mitry 1, Robin D Hughes 1, Anil Dhawan 1,*
PMCID: PMC3940404  PMID: 25755322

Abstract

Hepatocyte transplantation (HTx) has been developed for use in liver-based metabolic disorders and in acute liver failure. Worldwide, there are around 80 patients that have been transplanted with hepatocytes. Almost all reported studies prove feasibility and safety of the procedure with short- to medium-term success. Availability of good quality hepatocytes (HCs) is the main limiting factor, and therefore alternative sources of cells such as stem cells are being investigated. Other limiting factors include cell engraftment, survival, and function of transplanted cells. It remains to be seen if progress in HTx research can overcome these hurdles leading to the wider use of the technique as an alternative to liver transplantation in the future.

Keywords: Acute liver failure, hepatocyte transplantation, liver disease, stem cell transplantation

Abbreviations: ALF, acute liver failure; ApoB, apolipoprotein B; EGTA, ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetra-acetic acid; FVII, factor VII deficiency; GMP, good manufacturing practice; HAS, human serum albumin; HC, hepatocytes; HTx, hepatocyte transplantation; LDL, low density lipoprotein; LTx, liver transplantation; MRI, magnetic resonance imaging; OTC, ornithine transcarbamylase

Full Text

The Full Text of this article is available as a PDF (430.4 KB).

References

  • 1.Bilir BM, Guinette D, Karrer F. Hepatocyte transplantation in acute liver failure. Liver Transpl. 2000;6:32–40. doi: 10.1002/lt.500060113. [DOI] [PubMed] [Google Scholar]
  • 2.Strom SC, Fisher RA, Thompson MT. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation. 1997;63:559–569. doi: 10.1097/00007890-199702270-00014. [DOI] [PubMed] [Google Scholar]
  • 3.Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis. 1999;19:39–48. doi: 10.1055/s-2007-1007096. [DOI] [PubMed] [Google Scholar]
  • 4.Strom SC, Fisher RA, Rubinstein WS. Transplantation of human hepatocytes. Transplant Proc. 1997;29:2103–2106. doi: 10.1016/s0041-1345(97)00252-2. [DOI] [PubMed] [Google Scholar]
  • 5.Horslen SP, Fox IJ. Hepatocyte transplantation. Transplantation. 2004;77:1481–1486. doi: 10.1097/01.tp.0000113809.53415.c2. [DOI] [PubMed] [Google Scholar]
  • 6.Horslen SP, McCowan TC, Goertzen TC. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics. 2003;111:1262–1267. doi: 10.1542/peds.111.6.1262. [DOI] [PubMed] [Google Scholar]
  • 7.Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation. 2004;78:1812–1814. doi: 10.1097/01.tp.0000146386.77076.47. [DOI] [PubMed] [Google Scholar]
  • 8.Mitry RR, Dhawan A, Hughes RD. One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation. 2004;77:1614–1616. doi: 10.1097/01.tp.0000122224.98318.19. [DOI] [PubMed] [Google Scholar]
  • 9.Mito M, Ebata H, Kusano M, Onishi T, Hiratsuka M, Saito T. Studies on ectopic liver utilizing hepatocyte transplantation into the rat spleen. Transplant Proc. 1979;11:585–591. [PubMed] [Google Scholar]
  • 10.Weber A, Groyer-Picard MT, Franco D, Dagher I. Hepatocyte transplantation in animal models. Liver Transpl. 2009;15:7–14. doi: 10.1002/lt.21670. [DOI] [PubMed] [Google Scholar]
  • 11.Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31:890–896. doi: 10.1016/s0301-472x(03)00110-3. [DOI] [PubMed] [Google Scholar]
  • 12.Groth CG, Arborgh B, Bjorken C, Sundberg B, Lundgren G. Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation. Transplant Proc. 1977;9:313–316. [PubMed] [Google Scholar]
  • 13.Eguchi S, Rozga J, Lebow LT. Treatment of hypercholesterol-emia in the Watanabe rabbit using allogeneic hepatocellular transplantation under a regeneration stimulus. Transplantation. 1996;62:588–593. doi: 10.1097/00007890-199609150-00008. [DOI] [PubMed] [Google Scholar]
  • 14.Azuma H, Paulk N, Ranade A. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/II2rg-/-mice. Nat Biotechnol. 2007;25:903–910. doi: 10.1038/nbt1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.De Vree JM, Ottenhoff R, Bosma PJ, Smith AJ, Aten J, Oude Elferink RP. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology. 2000;119:1720–1730. doi: 10.1053/gast.2000.20222. [DOI] [PubMed] [Google Scholar]
  • 16.Malhi H, Joseph B, Schilsky ML, Gupta S. Development of cell therapy strategies to overcome copper toxicity in the LEC rat model of Wilson disease. Regen Med. 2008;3:165–173. doi: 10.2217/17460751.3.2.165. [DOI] [PubMed] [Google Scholar]
  • 17.DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky K. Lymphoid development in mice with a targeted deletion of the inter-leukin 2 receptor gamma chain. Proc Natl Acad Sci USA. 1995;92:377–381. doi: 10.1073/pnas.92.2.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Stephenne X, Najimi M, Smets F, Reding R, de Ville de Goyet J, Sokal EM. Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant. 2005;5:2058–2061. doi: 10.1111/j.1600-6143.2005.00935.x. [DOI] [PubMed] [Google Scholar]
  • 19.Meyburg J, Hoerster F, Weitz J, Hoffmann GF, Schmidt J. Use of the middle colic vein for liver cell transplantation in infants and small children. Transplant Proc. 2008;40:936–937. doi: 10.1016/j.transproceed.2008.03.043. [DOI] [PubMed] [Google Scholar]
  • 20.Stephenne X, Najimi M, Sibille C, Nassogne MC, Smets F, Sokal EM. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology. 2006;130:1317–1323. doi: 10.1053/j.gastro.2006.01.008. [DOI] [PubMed] [Google Scholar]
  • 21.Fisher RA, Strom SC. Human hepatocyte transplantation: worldwide results. Transplantation. 2006;82:441–449. doi: 10.1097/01.tp.0000231689.44266.ac. [DOI] [PubMed] [Google Scholar]
  • 22.Fox IJ, Chowdhury JR, Kaufman SS. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998;338:1422–1426. doi: 10.1056/NEJM199805143382004. [DOI] [PubMed] [Google Scholar]
  • 23.Darwish AA, Sokal E, Stephenne X, Najimi M, de Goyet Jde V, Reding R. Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl. 2004;10:1213–1215. doi: 10.1002/lt.20228. [DOI] [PubMed] [Google Scholar]
  • 24.Terry C, Dhawan A, Mitry RR. Optimization of the cryopreser-vation and thawing protocol for human hepatocytes for use in cell transplantation. Liver Transpl. 2010;16:229–237. doi: 10.1002/lt.21983. [DOI] [PubMed] [Google Scholar]
  • 25.Ambrosino G, Varotto S, Strom SC. Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant. 2005;14:151–157. doi: 10.3727/000000005783983250. [DOI] [PubMed] [Google Scholar]
  • 26.Allen KJ, Soriano HE. Liver cell transplantation: the road to clinical application. J Lab Clin Med. 2001;138:298–312. doi: 10.1067/mlc.2001.119148. [DOI] [PubMed] [Google Scholar]
  • 27.Lysy PA, Najimi M, Stephenne X, Bourgois A, Smets F, Sokal EM. Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives. World J Gastroenterol. 2008;14:3464–3470. doi: 10.3748/wjg.14.3464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Khan AA, Parveen N, Mahaboob VS. Treatment of Crigler-Najjar syndrome type 1 by hepatic progenitor cell transplantation: a simple procedure for management of hyperbilirubinemia. Transplant Proc. 2008;40:1148–1150. doi: 10.1016/j.transproceed.2008.03.022. [DOI] [PubMed] [Google Scholar]
  • 29.Muraca M, Gerunda G, Neri D. Hepatocyte transplantation as a treatment for glycogen storage disease type la. Lancet. 2002;359:317–318. doi: 10.1016/S0140-6736(02)07529-3. [DOI] [PubMed] [Google Scholar]
  • 30.Lee KW, Lee JH, Shin SW. Hepatocyte transplantation for glycogen storage disease type lb. Cell Transplant. 2007;16:629–637. doi: 10.3727/000000007783465019. [DOI] [PubMed] [Google Scholar]
  • 31.Sokal EM, Smets F, Bourgois A. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation. 2003;76:735–738. doi: 10.1097/01.TP.0000077420.81365.53. [DOI] [PubMed] [Google Scholar]
  • 32.Grossman M, Rader DJ, Muller DW. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med. 1995;1:1148–1154. doi: 10.1038/nm1195-1148. [DOI] [PubMed] [Google Scholar]
  • 33.Soriano H, Wood R, Kang D, Ozaki C, Finegold M, Bishoff F. Hepatocellular transplantation in children with fulminant liver failure. Hepatology. 1997;26:239A. [Google Scholar]
  • 34.Fisher RA, Bu D, Thompson M. Defining hepatocellular chi-merism in a liver failure patient bridged with hepatocyte infusion. Transplantation. 2000;69:303–307. doi: 10.1097/00007890-200001270-00018. [DOI] [PubMed] [Google Scholar]
  • 35.Habibullah CM, Syed IH, Qamar A, Taher-Uz Z. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation. 1994;58:951–952. doi: 10.1097/00007890-199410270-00016. [DOI] [PubMed] [Google Scholar]
  • 36.Sterling RK, Fisher RA. Liver transplantation. Living donor, hepatocyte, and xenotransplantation. Clin Liver Dis. 2001;5:431–460. doi: 10.1016/s1089-3261(05)70173-2. vii. [DOI] [PubMed] [Google Scholar]
  • 37.Schneider A, Attaran M, Meier PN. Hepatocyte transplantation in an acute liver failure due to mushroom poisoning. Transplantation. 2006;82:1115–1116. doi: 10.1097/01.tp.0000232451.93703.ab. [DOI] [PubMed] [Google Scholar]
  • 38.Baccarani U, Adani GL, Sanna A. Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient. Transpl Int. 2005;18:750–754. doi: 10.1111/j.1432-2277.2005.00127.x. [DOI] [PubMed] [Google Scholar]
  • 39.Mito M, Kusano M, Kawaura Y. Hepatocyte transplantation in man. Transplant Proc. 1992;24:3052–3053. [PubMed] [Google Scholar]
  • 40.Khan AA, Parveen N, Mahaboob VS. Management of hyperbilirubinemia in biliary atresia by hepatic progenitor cell transplantation through hepatic artery: a case report. Transplant Proc. 2008;40:1153–1155. doi: 10.1016/j.transproceed.2008.03.110. [DOI] [PubMed] [Google Scholar]
  • 41.Mitry RR, Hughes RD, Aw MM. Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant. 2003;12:69–74. doi: 10.3727/000000003783985197. [DOI] [PubMed] [Google Scholar]
  • 42.Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004;17:484–499. doi: 10.1002/nbm.924. [DOI] [PubMed] [Google Scholar]
  • 43.So PW, Kalber T, Hunt D. Efficient and rapid labeling of transplanted cell populations with superparamagnetic iron oxide nanoparticles using cell surface chemical biotinylation for in vivo monitoring by MRI. Cell Transplant. 2010;19:419–429. doi: 10.3727/096368910X498250. [DOI] [PubMed] [Google Scholar]
  • 44.Puppi J, Mitry RR, Modo M, Dhawan A, Raja A, Hughes RD. Use of a clinically-approved iron oxide MRI contrast agent to label human hepatocytes. Cell Transplant. 2011;20:963–975. doi: 10.3727/096368910X543367. [DOI] [PubMed] [Google Scholar]
  • 45.Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab D/s. 2006;29:431–435. doi: 10.1007/s10545-006-0245-8. [DOI] [PubMed] [Google Scholar]
  • 46.Shapiro AM, Lakey JR, Ryan EA. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230–238. doi: 10.1056/NEJM200007273430401. [DOI] [PubMed] [Google Scholar]
  • 47.Kubota H, Reid LM. Clonogenic hepatoblasts, common precur-sorsfor hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigen. Proc Nat! Acad Sei USA. 2000;97:12132–12137. doi: 10.1073/pnas.97.22.12132. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical and Experimental Hepatology are provided here courtesy of Elsevier

RESOURCES